Drug
D0133 | 5-Aminolevulinic Acid
L
L01XD04 Aminolevulinic acid
[L01XD] Sensitizers used in photodynamic/radiation therapy
[L01X] OTHER ANTINEOPLASTIC AGENTS
[L01] ANTINEOPLASTIC AGENTS
[L] Antineoplastic and immunomodulating agents
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
 |
Warning |
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure Respiratory tract irritation] |
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| 106-60-5 | 106A605 | 1451AA |
| 33871-EP2275420A1 | 33871-EP2295055A2 | 33871-EP2295416A2 |
| 33871-EP2298748A2 | 33871-EP2298764A1 | 33871-EP2298765A1 |
| 33871-EP2305642A2 | 33871-EP2305825A1 | 33871-EP2311453A1 |
| 33871-EP2311808A1 | 33871-EP2311829A1 | 35BEC718-C970-426A-9859-BF58284C60B4 |
| 4-Carboxy-2-Oxobutylamine | 4-oxo-5-amino-pentanoic acid | 5-ALA |
| 5-Amino-4-oxopentanoate | 5-Amino-4-oxopentanoic acid | 5-Amino-4-oxovalerate |
| 5-Amino-4-oxovaleric acid | 5-Aminolaevulinate | 5-Aminolaevulinic acid |
| 5-Aminolevulinate | 5-Aminolevulinic acid | 5-amino-4-oxo-Pentanoate |
| 5-amino-4-oxo-pentanoic acid | 5-amino-levulinate | 5-amino-levulinic acid |
| 5-aminolevulinicacidhydrochloride | 5-azanyl-4-oxidanylidene-pentanoic acid | 5ALA |
| 88755TAZ87 | AB00053763-07 | AB00053763-08 |
| AB00053763_09 | AB00053763_10 | AC-054 |
| AK-41254 | AKOS003587520 | ALBB-023627 |
| AS-30950 | AX8017444 | Aladerm |
| Ameluz | Amino-levulinic acid | Aminolevulinate |
| Aminolevulinic | Aminolevulinic Acid;ALA;5-Amino-4-oxopentanoic acid;5-amino-4-oxo-pentanoic acid;5-amino-4-keto-valeric acid | Aminolevulinic acid |
| BCP23830 | BDBM50240386 | BF-200 ALA |
| BIDD:GT0260 | BSPBio_003407 | C-49907 |
| C00430 | CCRIS 8958 | CHEBI:17549 |
| CHEMBL601 | CPD000857229 | CS-W000450 |
| D-aminolevulinic acid | D07567 | DALA |
| DB-040692 | DB00855 | DTXSID8048490 |
| DivK1c_006954 | EINECS 203-414-1 | FCH831578 |
| FT-0620021 | FVT | GTPL4784 |
| HMS2231I19 | HMS3259E22 | HMS3369O14 |
| HY-W000450 | KBio1_001898 | KBio2_002062 |
| KBio2_004630 | KBio2_007198 | KBio3_002627 |
| KBioGR_001176 | KBioSS_002062 | Kerastick |
| LMFA01100055 | LS-101793 | LS41389 |
| Levulinic acid, 5-amino- | Levulinic acid, 5-amino- (8CI) | MCULE-8676354165 |
| MLS001333097 | MLS001333098 | NC00601 |
| NCGC00178086-01 | PEN029 | Pentanoic acid, 5-amino-4-oxo- |
| Pentanoic acid, 5-amino-4-oxo- (9CI) | Q238474 | SAM002589919 |
| SBB071696 | SBI-0206721.P001 | SC-15622 |
| SCHEMBL8243 | SMR000857229 | SPBio_001843 |
| ST45026832 | SpecPlus_000858 | Spectrum2_001662 |
| Spectrum3_001654 | Spectrum4_000618 | Spectrum5_001505 |
| Spectrum_001582 | UNII-88755TAZ87 | Z-3294 |
| ZGXJTSGNIOSYLO-UHFFFAOYSA-N | ZINC3782550 | ZX-AN022141 |
| delta-ALA | delta-aminolevulinate | delta-aminolevulinic acid |
| DrugBank Name | Aminolevulinic acid |
| DrugBank | DB00855 |
| CAS Number | 106-60-5, 5451-09-2 |
| PubChem Compound | 137 |
| KEGG Compound ID | C00430 |
| KEGG Drug | D07567 |
| PubChem.Substance | 46506856 |
| ChEBI | 17549 |
| PharmGKB | PA10015 |
| ChemSpider | 134 |
| BindingDB | 50240386.0 |
| TTD | DAP000314 |
| Wikipedia | Aminolevulinic acid |
| HET | FVT |
1. Onuki et al., 2004